Missouri students advocate for statewide science fair
The only problem is Missouri currently does not have a statewide fair for students of all ages to compete for the next scientific breakthrough.
Murder Solved in 20 Days: Inside the case that brought down a killer
The science teacher who accompanied the dozen or so science scholars estimated a statewide science fair would cost around $600,000, but she added a local university has already agreed to host it.
Fox 2 is reaching out to several agencies and STEM-centered companies in Missouri for reaction regarding the lack of a statewide showcase of science in the Show-Me state. State agencies we're reaching out to include the Missouri Department of Conservation, the Missouri Department of Natural Resources and the Missouri Department of Health and Senior Services.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
6 days ago
- Yahoo
Stargazers dazzled as spirals of light appear in night sky
Stargazers on the lookout for the Perseid meteor shower were treated to an extra nighttime spectacular on Tuesday night as spirals appeared in the sky along the East Coast. The unusual light show -- which appeared to show circling lights in the heavens -- was on display after multiple rocket launches. MORE: SpaceX loses another Starship in latest launch, with debris seen streaking across the sky Videos began circulating online in several states, including Maryland, New York, New Jersey, Tennessee, Illinois, Ohio and Nebraska, after 9 p.m. ET Tuesday, social media posts show. ABC Philadelphia station WPVI began receiving calls and messages from viewers around 10:30 p.m. to report the phenomenon, the station reported. The spiraling lights seemed to appear "out of nowhere," Blake Brown, who witnessed the dazzling display from Algonquin, Illinois, while watching for the meteor shower, told ABC News. MORE: Rare wave-shaped clouds hovering over Virginia skyline caught on camera The majority of the spiraling light sightings likely stemmed from the launch of Ariane 6, said Jonathan C. McDowell, an astrophysicist for the Harvard-Smithsonian Center for Astrophysics. That rocket lifted off from the Guiana Space Centre at Europe's Spaceport in Kourou, French Guiana, at about 8:37 p.m. ET, according to Eumetsat, a European operational satellite agency for monitoring weather. Ariane 6, about 196-feet tall, has the ability to launch both heavy and light payloads for applications such as Earth observation, telecommunication, meteorology, science and navigation, according to the European Space Agency. The appearance of the spirals in the sky was likely the result of the upper stage of the rocket tumbling as it underwent a disposal rocket firing at the end of the launch, McDowell told ABC News. MORE: Falling space debris is increasingly threatening airplanes, researchers say The spiral light occurs when reflection from sunlight interacts with the frozen plume of fuel from the exhaust of rockets. "It's a nice, perfect spiral because it's way out in space with no air to distort the shape," McDowell said. Tuesday's launch, which brought a weather satellite to orbit, is the third-ever mission for the powerful rocket, according to Another rocket, the Vulcan Centaur Rocket, successfully lifted off from the Cape Canaveral Space Force Station in Florida at 8:56 p.m. ET, according to the United Launch Alliance. The 202-foot rocket was carrying a pair of experimental navigation satellites on behalf of the United States Space Force's first-ever mission, according to "The Vulcan launched east and went to a high orbit, and was still coasting upward [without the rocket firing] when the spiral was seen," McDowell said. "If people in Florida saw something at 9:37, 9:45 pm ET, that could have been the Vulcan."
New York Post
07-08-2025
- New York Post
Debilitating illness once dismissed as ‘yuppie flu' actually has genetic causes: study
Tired all the time? It might be in your DNA. A new study has uncovered striking genetic differences in people suffering from a devastating illness that causes extreme exhaustion, chronic pain and brain fog that can last for months, years or even decades. Researchers are calling the discovery a 'wakeup call' that could finally shift public perception of the poorly understood condition, once dismissed as a 'fashionable form of hypochondria' and labeled the 'yuppie flu' by doctors, despite its often debilitating effects. 3 The condition disproportionately affects women around the world. Maridav – Chronic fatigue syndrome, also known as myalgic encephalomyelitis or ME/CFS, is believed to affect 67 million people worldwide — including an estimated 3.3 million Americans. Until recently, little was known about what causes the crippling illness, which can turn a short walk into a major flare-up that leaves many patients bedbound with symptoms that rest doesn't relieve. For years, doctors categorized ME/CFS as a psychosomatic issue rather than a physical disorder. But a growing body of research, including the latest genetic findings, suggests there is a clear biological basis. 'ME/CFS is a serious illness and we now know that someone's genetics can tip the balance on whether they are diagnosed with it,' Dr. Chris Ponting, lead investigator at the University of Edinburgh, said in a statement. The study analyzed DNA samples from more than 15,500 people of European ancestry with ME/CFS as part of DecodeME, the world's largest dataset on the disease. Researchers found eight key regions of DNA where differences were far more common in ME/CFS patients than in the general population. 3 Human DNA may hold clues to why some people develop ME/CFS. vitstudio – Two of those DNA signals are linked to the body's response to infection, aligning with frequent patient reports that symptoms began after recovering from an infectious illness. Another genetic marker overlaps with chronic pain — a common complaint among ME/CFS sufferers. 'As DNA doesn't change with ME/CFS onset, these findings reflect causes rather than effects of ME/CFS,' the researchers wrote. 'These results are groundbreaking,' said Sonya Chowdhury, CEO of the charity Action for ME and DecodeME co-investigator. 'We've gone from knowing almost nothing about ME/CFS causes to pinpointing clear targets for research.' While researchers say the findings are not yet ready to guide diagnosis or treatment, they provide vital clues about the disease's origins and could pave the way for future breakthroughs. 3 Many people with ME/CFS say their symptoms first appeared after recovering from a viral illness. LuneVA/ – 'We are shining a laser light on eight precise areas of DNA, so that highly focused research can now be carried out,' Chowdhury said. 'We hope this attracts researchers, drug developers, and proportionate funding to ME/CFS — and speeds up the discovery of treatments.' Currently, there is no diagnostic test, effective treatment, or cure for ME/CFS, according to the Centers for Disease Control and Prevention. Instead, doctors typically focus on relieving symptoms through interventions such as medication, stretching and movement therapies, acupuncture, or massage. They may also recommend lifestyle strategies such as pacing, a method that helps ME/CFS patients manage their activity levels to reduce the frequency and severity of relapses while staying as active as possible. The study is currently a preprint from the University of Edinburgh and has not been peer-reviewed yet. The DecodeME team is urging researchers worldwide to tap into their dataset and launch new, targeted studies on ME/CFS, especially around these eight newly identified genetic signals.
Newsweek
07-08-2025
- Newsweek
Study Finds Genetics Could Cause This Chronic Condition
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. A new study has revealed that those with myalgic encephalomyelitis or chronic fatigue syndrome (ME/CFS) have notable genetic differences from the general population. The DecodeME research team, led by experts at the University of Edinburgh in Scotland, noted that, as DNA does not change following an onset of ME/CFS, the findings indicate that genetic signals may be a cause of the condition. "This is the first robust genetic evidence that there is a predisposition to ME/CFS written into our DNA," Chris Ponting, principal investigator of the study, chair of Medical Bioinformatics and investigator at the MRC Human Genetics Unit, Institute of Genetics and Cancer, at the University of Edinburgh, told Newsweek. "For years, people with ME/CFS have felt dismissed and their symptoms ignored," he said. DecodeME has been investigating many other diseases over the last 15 years, and Ponting said that, "in this sense, DecodeME has come 15 years too late." "ME/CFS research and people with ME/CFS should have had the benefit of its approach over all those intervening years," he said. "We think it's been delayed because ME/CFS is a highly stigmatized disease, and because it is highly biased towards women," he added, saying that now, DecodeME's research "puts ME/CFS on a more equal footing with other research and provides a clear map of where future research should now be focused." Stock image of a woman in pain lying in bed. Stock image of a woman in pain lying in Is ME/CFS? ME/CFS is a long-term condition that can affect different parts of the body, resulting in a wide range of debilitating symptoms. The most commonly recognized symptom is extreme fatigue, a degree of fatigue that far exceeds tiredness, which can limit a patient's ability to carry out daily activities, work and exercise, while also causing sleep problems like insomnia or non-restorative sleep. Other symptoms include cognitive issues and difficulty, affecting concentration and memory, as well as headaches, joint and muscle aches, flu-like symptoms, and many others. Many patients also notice their symptoms worsen following physical, mental or emotional exertion, which is known as post-exertional malaise, or PEM, and patients can take days to weeks to recover from these flares in symptoms. Depending on the severity of the condition, even a short walk or other activities that might seem insignificant to someone without the condition could trigger major flares in symptoms. The condition, therefore, has a profound impact on a patient's life, leaving many bedbound and others significantly limited in what they can do in a day. Tens of millions worldwide have the condition, with estimates on U.S. prevalence varying between just less than a million to 1.5 million, according to the American Myalgic Encephalomyelitis and Chronic Fatigue Syndrome Society. It typically affects more women than men, and in most cases starts following an infection, with the COVID pandemic increasing the number of cases, according to a January 2025 study in the Journal of General Internal Medicine. However, the condition can be easily misdiagnosed, according to ME Research UK, making it difficult to know the exact number of those with the illness. What Did the Study Find? The DecodeME study found eight different genetic signals between those with ME/CFS and those without. The researchers analyzed 15,579 DNA samples of those with ME/CFS and the DNA of 259,909 people without ME/CFS, all of European descent. The eight genetic signals found to be different between ME/CFS patients and those without the condition were involved in both the immune and the nervous systems, which the researchers said suggested there are immunological and neurological causes behind the illness. There were also at least two signals found to relate to the body's response to infection. "Finding variations in genes that differ between people with or without a disease can therefore point to what causes it," the researchers wrote. However, the researchers noted that as these differences can also be found in people without ME/CFS, the findings cannot "cleanly separate who is at risk and who is not, and therefore do not provide a definitive test." There was also no clear explanation found as to why more women than men get the condition, the researchers added. "The initial results of this huge study are ground breaking," Julia Newton, a consultant physician specializing in fatigue at the Newcastle Upon Tyne Hospitals and a medical director of the Academic Health Science Network in North East and North Cumbria, England, told Newsweek. "The research team from Edinburgh have shown that those with a diagnosis of ME/CFS have differences in their genes which suggests that there may be a biological abnormality in individuals that could make them more susceptible to getting ME/CFS or to having persistent disease," Newton, who was not involved in the study, said. File photo: participants walk through Frankfurt city center during a demonstration to support people with myalgic encephalomyelitis and/or chronic fatigue syndrome (ME/CFS) and to call for more research into the disease. File photo: participants walk through Frankfurt city center during a demonstration to support people with myalgic encephalomyelitis and/or chronic fatigue syndrome (ME/CFS) and to call for more research into the disease. Frank Rumpenhorst/dpa via AP The 'Stigma' Around ME/CFS When ME/CFS was first described 40 years ago, "the usual laboratory tests ordered by doctors came back normal," Dr. Anthony Komaroff, a professor of medicine at the Harvard Medical School and a senior physician at Brigham and Women's Hospital not involved in the study, told Newsweek. "This led some doctors to claim the illness was psychological, and that there were no underlying objective abnormalities," he said. He said that some still hold that view because, "in my opinion, they have not bothered to keep up with the science." "In fact, we now know there are multiple underlying abnormalities involving the brain, immune system, energy metabolism, vascular system, and gut microbiome," he said. "The DecodeME study provides additional evidence that ME/CFS is not primarily a psychological illness," he added. In light of that, Newton said that the findings are a "game changer for our understanding of the disease and also its perception." "For decades, those with ME/CFS have been stigmatized and confirming a genetic difference in those with the condition vindicates the struggle that the ME/CFS community has had, to recognize ME/CFS as a physical condition that impacts individuals with the same, or greater, severity as other chronic medical conditions," she said. Importantly, the researchers note that their findings reveal "no evidence that the eight ME/CFS genetic signals share common causal genetic variants with depression or anxiety," affirming that, despite the misconception, the disease is not psychological. "ME/CFS has often been misdiagnosed as depression or anxiety," Ponting said. "We checked whether DecodeME's eight genetic signals had been found before for other diseases, but drew a blank." Sir Simon Wessely, a professor of psychological medicine at King's College London told Newsweek that there is already "ample evidence that ME/CFS is not the same as depression, but that previous depression increases the risk of developing ME/CFS, which needs explaining, and I would be surprised if genetics does not play some part in this." He said that while it is understood ME/CFS is not an anxiety disorder, "anxiety can impede recovery." "The fact that ME/CFS involves both excessive physical and mental fatigue and fatiguability after both physical and mental exertion already tells us that the causes are most likely to be central, i.e., the brain, rather than peripheral—these new findings reinforce that, but we are still a long way from knowing why," he said. "Unravelling multigenic and multi factorial conditions such as ME/CFS is going to be a long haul, as those who have been researching the genetics of psychiatric disorders have already found out," he added. What Does This Mean For ME/CFS Treatment? "We've always said that DecodeME results will not lead directly to new treatments or diagnostic tools," Ponting said. "Rather, what they do is guide where further research needs to be focused." He said that scientists from around the world now need to "use their expertise to find out exactly what DecodeME's genetic signals mean and this, in turn, should help accelerate finding treatments for ME/CFS." Ponting said that some people with ME/CFS have informed DecodeME that the results have been "validating." "They tell us that these results will help them in conversations with medical professionals, family and friends, to be believed, taken seriously and to obtain support," he said. "Many also tell us that they are giving them hope, where there has been none before, and are lifting the burden from their shoulders of the guilt and self-doubt that they have built up from not being believed," he added. Komaroff said that he expected the DecodeME study "will increase research into the specific problems with the brain and immune system in people with ME/CFS, and this research may then lead to identifying possible new treatments." "I would like to think that it will generate even more interest in the scientific community to study the underlying biology of the illness, and more funding for those studies," he added. Newton said the findings "point towards potential targets for further study and then ultimately focused treatments." "I sincerely hope that this study, resets the narrative around ME/CFS, encourages further research in this debilitating disease and begins the path towards effective, evidence based treatments," she said. She added that "there is a long road ahead but I am optimistic that this is the start of a journey that will improve the lives of those with ME/CFS and perhaps even eradicate it."
